Key result
The aSAH-Risk score predicts unfavorable 6-month outcomes in ~48% of aneurysmal subarachnoid hemorrhage patients.
Why the study?
Predictive tools for assessing outcomes after aneurysmal subarachnoid hemorrhage are limited, particularly regarding long-term functional outcome, though early risk stratification is crucial to guide management and resource use.
Observational (n=230)
No
The newly developed aSAH-Risk score, which incorporates cardiovascular risk factors like arterial hypertension and vasosclerosis alongside clinical severity, can help identify patients at high risk for unfavorable long-term functional outcomes after aneurysmal subarachnoid hemorrhage.
May identify high-risk aSAH patients for intensified follow-up; extends prior tools by adding cardiovascular risk factors but needs validation.
Background Predictive tools for assessing outcomes after aneurysmal subarachnoid hemorrhage (aSAH) are limited, particularly with respect to long-term functional outcome. Reliable risk stratification in the early course of aSAH is crucial for determining optimal patient management, effective use of clinical resources, and ultimately improving patient outcomes. This study aimed to design a prognostic score based on retrospectively collected clinical variables to predict functional outcome or delayed cerebral ischemia as primary endpoints in patients with aSAH. Methods Between January 2014 and March 2022, 386 patients with aSAH were admitted to our hospital. Two hundred thirty of these patients were included in our study. Seventeen clinical, radiological, and demographic variables were analyzed using the chi-squared test and logistic regression to identify significant predictors of an unfavorable outcome (mRS 4–6) after 6 months or DCI development. A nomogram defined the weighting of each factor within a newly developed aSAH-Risk score. Results Significant risk factors were identified to predict functional outcome. Of these, five variables were included to create the aSAH-Risk score with a maximum of 13 points: arterial hypertension ( p = 0.001, no = 0, yes = 2), intracranial vasosclerosis ( p = 0.0002, none = 0, yes = 2), modified Fisher scale ( p < 0.001, scale 1 = 0, scale 3 = 2, scale 2 or 4 = 3), intracerebral hemorrhage (no = 1, yes = 2) and World Federation of Neursosurgical Societies grading ( p < 0.001, 1 = 0, 2 = 1, 3 or 4 = 3, 5 = 4). Forty percent was the minimal calculated risk of an unfavorable outcome for an aSAH patient, increasing to 80% with an aSAH-Risk score of 13 points. An external cohort is required to validate the proposed score for general applicability. Conclusion The aSAH-Risk score is a novel clinical tool to identify patients in need of long-term daily life assistance at admission.
No takes yet. Share an insight, caveat, or question.
Ritter et al. (2026) conducted an observational in aneurysmal subarachnoid hemorrhage (aSAH) (n=230). aSAH-Risk score was evaluated on unfavorable outcome (mRS 4-6) at 6 months. The aSAH-Risk score predicts an unfavorable outcome in 47.8% of patients with aneurysmal subarachnoid hemorrhage at 6 months follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: